JPY 1090.0
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -248.29 Million JPY | 31.48% |
2022 | -362.34 Million JPY | -170.31% |
2021 | -134.04 Million JPY | 22.28% |
2020 | -172.47 Million JPY | -34.74% |
2019 | -128 Million JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -20 Million JPY | -93.84% |
2023 Q2 | -65.55 Million JPY | 31.94% |
2023 Q4 | -10.31 Million JPY | 86.44% |
2023 Q3 | -76.11 Million JPY | -16.11% |
2023 FY | -248.29 Million JPY | 31.48% |
2023 Q1 | -96.31 Million JPY | -106.1% |
2022 Q3 | -109 Million JPY | -11.23% |
2022 FY | -362.34 Million JPY | -170.31% |
2022 Q4 | -46.73 Million JPY | 57.13% |
2022 Q2 | -97.99 Million JPY | 0.0% |
2021 FY | -134.04 Million JPY | 22.28% |
2020 FY | -172.47 Million JPY | -34.74% |
2019 FY | -128 Million JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 5.53 Billion JPY | 104.489% |
Cosmo Bio Company,Limited | 442 Million JPY | 156.175% |
H.U. Group Holdings, Inc. | -7.55 Billion JPY | 96.713% |
FALCO HOLDINGS Co., Ltd. | 1.66 Billion JPY | 114.904% |
BML, Inc. | 6.03 Billion JPY | 104.115% |
Human Metabolome Technologies, Inc. | 243.24 Million JPY | 202.074% |
Precision System Science Co., Ltd. | -1.12 Billion JPY | 77.86% |